ContraFect Corporation
CFRXQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $154 | $148 | $168 | $169 |
| Gross Profit | -$154 | -$148 | -$168 | -$169 |
| % Margin | – | – | – | – |
| R&D Expenses | $44,738 | $35,508 | $22,614 | $18,057 |
| G&A Expenses | $12,151 | $11,757 | $11,625 | $9,809 |
| SG&A Expenses | $12,151 | $11,609 | $11,457 | $9,640 |
| Sales & Mktg Exp. | $0 | -$148 | -$168 | -$169 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $56,889 | $47,117 | $34,071 | $27,697 |
| Operating Income | -$56,889 | -$47,265 | -$34,240 | -$27,866 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8,264 | $26,983 | $6,084 | $15,072 |
| Pre-Tax Income | -$65,153 | -$20,282 | -$28,156 | -$12,794 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65,153 | -$20,282 | -$28,156 | -$12,794 |
| % Margin | – | – | – | – |
| EPS | -124.97 | -44.12 | -98.95 | -123.57 |
| % Growth | -183.3% | 55.4% | 19.9% | – |
| EPS Diluted | -124.97 | -44.12 | -98.95 | -123.57 |
| Weighted Avg Shares Out | 521 | 460 | 285 | 104 |
| Weighted Avg Shares Out Dil | 521 | 460 | 285 | 104 |
| Supplemental Information | – | – | – | – |
| Interest Income | $81 | $109 | $192 | $359 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $154 | $148 | $168 | $169 |
| EBITDA | -$64,999 | -$20,134 | -$27,987 | -$12,625 |
| % Margin | – | – | – | – |